Concepedia

Benjamin Jones

BJ

Statistics

Publications

9

Citations

797

H-Index

9

Active since

2013

Affiliations

University of Alabama at Birmingham(Current)

University of California, Los Angeles

Benjamin Jones is an author at University of Alabama at Birmingham specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2013–2022

9

Publications

9

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 592 citations · Full text

Medicine, Oncology, Pharmacology +15

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer

Siwen Hu‐Lieskovan, Aaron Lisberg, Jesse M. Zaretsky et al. · Clinical Cancer Research · 2019 · 72 citations · Full text

Medicine, Immunology, Oncology +17

Medical 3D Printing Dimensional Accuracy for Multi-pathological Anatomical Models 3D Printed Using Material Extrusion

Prashanth Ravi, Leonid Chepelev, Gabrielle V. Stichweh et al. · Journal of Digital Imaging · 2022 · 34 citations · Full text

Engineering, Anatomy, Biomedical Engineering +16

Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab

Nathan Gundacker, Stephen J. Jordan, Benjamin Jones et al. · Open Forum Infectious Diseases · 2016 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +17

Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer

Zorawar S. Noor, Jonathan W. Goldman, William Lawler et al. · Lung Cancer · 2019 · 19 citations

Medicine, Oncology, Pharmacology +10

1–5 of 9